LifeMap Solutions, a digital-health subsidiary of BioTime, known for its ResearchKit-enabled app Asthma Health, has announced that its HealthKit-compliant iOS app, COPD Navigator, is now available for free download from the App Store.
Developed in close partnership with researchers from the Icahn School of Medicine at Mount Sinai and leading pulmonologists from the Mount Sinai – National Jewish Health Respiratory Institute, the app empowers patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD) to better monitor and manage their condition.
An enhanced version branded as SuperCare iBreathe will be clinically deployed by SuperCare Health, a chronic care management company specialising in respiratory diseases. The iBreathe app is customised with unique data collection points and allows SuperCare Health’s clinical care team to track them in real time and respond immediately to COPD patients enrolled in their Healthcare at Home programme. This marks the first commercial revenue by LifeMap Solutions. Financial details were not disclosed.
“LifeMap Solutions is dedicated to building mHealth apps that positively, powerfully affect patients’ quality of life,” said CEO of LifeMap Solutions, Corey Bridges.
“We’ve built our first two apps to help sufferers of asthma and COPD, and we’re working to expand our impact across a wider range of chronic conditions. With COPD Navigator, we’re aiming not only to empower patients to manage their own health more easily, but also to engage more deeply with their care providers. We believe that the key to this is COPD Navigator’s summary screens for patients’ health data. Just as happened with the Doctor Dashboard feature in our Asthma Health app, patients will show COPD Navigator to their doctors and initiate data-driven conversations. And through our partner SuperCare Health, we’re gratified to deploy our technology directly into a patient-care setting,” continued Bridges.
The app leverages evidence-based care guidelines, behavioural science and patient data to improve patient adherence with the goal of achieving better health outcomes at lower cost. COPD Navigator users receive real-time local weather and air quality alerts, medication reminders, and tools to track their symptoms in order to more quickly recognise COPD exacerbations, in which their lung condition suddenly worsens.
COPD Navigator also empowers patients to easily share this information with their healthcare teams. This gives patients the flexibility to address exacerbations at home under their doctor’s guidance and potentially prevent an expensive medical emergency.
“Ongoing guidance and insight from care teams amplify the benefits gained from using self-management tools, which is why an effective mHealth solution has to cater to both patients and care teams to maximise value,” said CEO of Mount Sinai – National Jewish Health Respiratory Institute, Charles Powell, MD.
“With COPD Navigator, patients can easily share their self-reported health information with care teams to address exacerbations in their conditions at home under proper guidance, potentially preventing expensive emergency room visits or inpatient hospital stays,” continued Powell.